Brevibacillin V

General Information


DRACP ID  DRACP04350

Peptide Name   Brevibacillin V

Sequence  XLXIVVKVVKYLX

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  2-OH-ME-C5

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C59H98N12O9

Absent amino acids  ACDEFGHMNPQRSTW

Common amino acids  V

Mass  166373

Pl  10.25

Basic residues  2

Acidic residues  0

Hydrophobic residues  7

Net charge  2

Boman Index  1968

Hydrophobicity  152.31

Aliphatic Index  179.23

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34220785

Title  Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity

Doi Not available

Year  2021

Literature 2

Pubmed ID 31674183

Title  Discovery of a Novel Antimicrobial Lipopeptide, Brevibacillin V, from Brevibacillus laterosporus fmb70 and Its Application on the Preservation of Skim Milk

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18997

DRACP is developed by Dr.Zheng's team.